Nanocarriers for Therapeutics Delivery of Cardiovascular Disease
Pp. 40-51 (12)
Cardiovascular diseases are presently the leading cause of death worldwide.
Prescribed drugs in terms of therapeutic modalities of clinical management have treated
patients, but still a limitation exists. This administered drug displays unwanted health
adversity due to the side effects. In this regard, the current focus has been drawn
towards nanomedicine-based drug formulation, which illustrates better therapeutic
ability, sustained release, bioavailability and less toxicity. To address this, various
nanocarriers are developed and are being involved in and studied for clinical
application. In this chapter, the potential application of different nanocarrier-based
therapeutic delivery has been discussed.
Coronary artery disease, Dendrimers, Liposomes, Nanomedicine,